Somatropin
Somatropin is a synthetic human growth hormone used to treat growth failure in children and growth hormone deficiency in adults, available under several brand names including Humatrope, Norditropin, Omnitrope, and others.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 5 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
📖 Somatropin: Patient Information Guide
A plain-language walkthrough of Somatropin — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What it's used for▾
Somatropin is a synthetic growth hormone used across several brand-name products to treat conditions where the body cannot make enough growth hormone on its own.
- Growth failure in children caused by growth hormone deficiency (GHD) — supported by Humatrope, Norditropin, and Omnitrope, among others
- Prader-Willi Syndrome in children — supported by Norditropin and Omnitrope
- Short stature in children born small for gestational age (SGA) who don't catch up by age 2 — supported by Humatrope, Norditropin, and Omnitrope
- Turner Syndrome in girls — supported by Humatrope, Norditropin, and Omnitrope
- Idiopathic short stature (ISS) — unexplained short stature not caused by another treatable condition — supported by Humatrope, Norditropin, and Omnitrope
- SHOX gene deficiency causing short stature — supported by Humatrope
- Noonan Syndrome in children — supported by Norditropin
- Growth hormone deficiency in adults, whether the deficiency began in childhood or developed in adulthood — supported by Humatrope, Norditropin, and Omnitrope
⚙️How it works▾
Somatropin is identical in structure to the growth hormone your pituitary gland naturally produces. It activates growth hormone receptors throughout the body, prompting the liver and other tissues to release IGF-1 (insulin-like growth factor-1). IGF-1 is the main driver of bone lengthening in children, increasing both the number and size of muscle cells, and supporting protein building throughout the body. In adults with deficiency, somatropin helps shift body composition — reducing fat mass (especially around the abdomen) and increasing lean muscle — while also improving how the body handles fats and cholesterol.
Somatropin also affects how the body manages carbohydrates and minerals. It can reduce insulin sensitivity at higher doses and promotes retention of potassium, phosphorus, and sodium as part of normal cell growth. In children with low blood sugar related to pituitary problems, it can help stabilize glucose levels — but large doses may impair glucose tolerance.
💊How it's taken▾
Somatropin is given as a subcutaneous injection — just under the skin — and is never taken by mouth. Children typically receive injections 6 to 7 days per week, with the weekly dose divided into daily injections. Adults usually inject once daily, often at bedtime. Injection sites (abdomen, thigh, upper arm, or buttock) should be rotated every time to prevent skin changes.
- Dosing is highly individualized — your prescriber will adjust the dose based on your response and lab results over time
- Never change your dose or schedule without talking to your doctor first
- Follow the specific preparation and storage instructions for your brand — some products require reconstitution before use
🤒Side effects — in detail▾
Like all medications, somatropin can cause side effects — some common and manageable, others requiring medical attention.
- Upper respiratory infections, sore throat, and fever
- Headache
- Ear infections (especially in children with Turner Syndrome)
- Swelling in the hands, feet, or body (fluid retention)
- Joint pain, muscle aches, or back pain
- Numbness or tingling — including carpal tunnel syndrome (nerve compression in the wrist)
- Increased blood sugar or glucose intolerance
- Skin dimpling at the injection site (lipoatrophy) if the same spot is used repeatedly
More serious reactions — such as severe allergic reactions, signs of increased brain pressure (bad headache, vision changes, nausea), a child limping or reporting hip pain, or persistent severe stomach pain — require prompt medical attention. Contact your doctor right away if any of these occur.
⚠️Warnings & precautions▾
- Prader-Willi Syndrome in children: Children with this condition who are severely obese or have breathing problems (including sleep apnea) face a risk of sudden death. A thorough evaluation for airway and breathing problems is required before starting somatropin, and treatment should be stopped if new breathing issues develop.
- Critically ill patients: Somatropin is not safe for people in intensive care recovering from major surgery, serious trauma, or acute respiratory failure — clinical studies showed significantly higher death rates in this setting.
- Active cancer: Somatropin must not be used if there is any active malignancy. Patients with a history of brain tumors or cancer should be monitored carefully for any recurrence during treatment.
- Blood sugar changes: Somatropin can reduce insulin sensitivity and may unmask type 2 diabetes. Regular blood sugar monitoring is essential, especially in people with risk factors like obesity or Turner Syndrome.
- Intracranial hypertension (raised pressure in the skull): Can develop, usually in the first 8 weeks of treatment. Symptoms include severe headache, vision changes, nausea, or vomiting. An eye exam is recommended before starting treatment.
- Slipped capital femoral epiphysis: A hip growth plate injury that can occur in children on somatropin — report any new limp or hip/knee pain immediately.
- Benzyl alcohol: Some somatropin formulations contain benzyl alcohol as a preservative, which can be dangerous for premature infants and low-birth-weight babies. Preservative-free options should be used in these situations.
🔀What it interacts with▾
Somatropin can interact with several medications, affecting how well they work or increasing the risk of side effects.
- Glucocorticoids (steroids like prednisone or cortisone acetate): Somatropin lowers cortisol levels — people on steroid replacement therapy may need higher doses. High-dose steroids can also blunt somatropin's growth effects in children.
- Insulin and diabetes medications: Somatropin reduces the body's response to insulin, so blood sugar medications may need dose adjustments.
- Oral estrogen: Taken by mouth, estrogen can reduce the IGF-1 response to somatropin — higher somatropin doses may be needed for women on oral estrogen replacement.
- CYP450-metabolized drugs: Somatropin speeds up the liver's processing of many medications. If you take drugs that are broken down by liver enzymes, your doctor may need to monitor levels more closely.
This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.
📋Before taking it▾
- Do not use somatropin if you have an active cancer or malignancy of any kind
- Do not use during acute critical illness — including after major heart or abdominal surgery, serious trauma, or acute respiratory failure
- Children with Prader-Willi Syndrome who are severely obese, have sleep apnea, or have significant breathing problems should not use somatropin
- Do not use if you have active proliferative or severe non-proliferative diabetic retinopathy (serious eye damage from diabetes)
- Not for use in children whose growth plates (epiphyses) are already closed — it won't promote further height and is not indicated
- Tell your doctor if you have diabetes, thyroid disease, a history of cancer, scoliosis, or adrenal gland problems
- Older adults are more sensitive to somatropin's effects — lower starting doses are generally recommended
- If you are pregnant or breastfeeding, discuss this with your doctor; some formulations contain benzyl alcohol, which should be avoided — preservative-free alternatives or reconstitution with saline may be recommended
- Known allergy to somatropin or any ingredient in the product is a contraindication
🚑If you take too much▾
Taking too much somatropin in the short term can first cause low blood sugar (hypoglycemia) and then high blood sugar (hyperglycemia), along with fluid retention (swelling). Over a long period, excessive doses could lead to abnormal bone and tissue growth — the kinds of changes seen with too much growth hormone, such as gigantism in children or acromegaly (thickening of bones and enlargement of hands, feet, and facial features) in adults. If you suspect an overdose, contact your healthcare provider or poison control right away.
📡Pharmacodynamics — effects in the body▾
Somatropin's primary action is stimulating linear (height) growth in children by acting on the cartilaginous growth plates at the ends of long bones. It does this mainly through IGF-1, which it triggers the liver and kidneys to produce. Beyond growth, somatropin increases muscle cell number and size, promotes protein synthesis, stimulates fat breakdown (reducing body fat stores and lowering LDL cholesterol in people with GHD), and affects how the body retains minerals like potassium and phosphorus. It also increases red blood cell mass and influences the size of internal organs.
🔬Pharmacokinetics — how your body processes it▾
When injected subcutaneously (under the skin), about 80% of a somatropin dose reaches the bloodstream — a high absorption rate compared to an intravenous dose used as a reference. Peak blood levels are reached roughly 5 to 6 hours after a subcutaneous injection. The drug has a relatively short half-life: about 0.4 hours when given directly into a vein, but around 3 hours after a subcutaneous injection, because it is absorbed gradually from the injection site. Somatropin is broken down primarily in the liver and kidneys through normal protein metabolism, and some breakdown products are returned to the bloodstream before being cleared.
📦How to store it▾
Store ZOMACTON vials refrigerated at 36° to 46°F (2° to 8°C) in the original carton to protect from light. Avoid freezing the accompanying diluent. store ZOMACTON 5 mg vials that have been reconstituted with co-packaged Bacteriostatic Sodium Chloride Injection, USP (with 0.
📄 Written from Somatropin’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
🩺 Pharmacist Counseling Corner
Quick, plain-English answers to the questions patients ask most about Somatropin — the kind of thing our pharmacy team would talk through with you at the counter.
What exactly is somatropin and why has my doctor prescribed it? ▾
How do I give the injection, and does it hurt? ▾
What side effects should I expect, and which ones should make me call the doctor right away? ▾
Will somatropin affect my blood sugar or my diabetes medications? ▾
Are there any medications or supplements I should tell my doctor about before starting somatropin? ▾
Is somatropin safe during pregnancy or breastfeeding? ▾
Is Somatropin available over the counter? ▾
When was Somatropin first available? ▾
Who makes Somatropin? ▾
💬 Answers drafted from Somatropin’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
💊 How Somatropin comes
Somatropin is available in 3 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Injection
How this form is used
- Humatrope is used for growth failure due to GHD, Turner Syndrome, idiopathic short stature, SHOX deficiency, SGA, and adult GHD
- Norditropin is used for GHD, Noonan Syndrome, Turner Syndrome, SGA, ISS, Prader-Willi Syndrome, and adult GHD
- Omnitrope is used for growth failure in children due to GHD, Prader-Willi Syndrome, SGA, Turner Syndrome, and ISS, as well as adult GHD
- All subcutaneous injection products are given by injection just under the skin, with injection sites rotated to prevent skin changes
- Inject subcutaneously into the abdomen, thigh, upper arm, or buttock — rotate sites every time to avoid skin dimpling
- Omnitrope cartridges (5 mg/1.5 mL and 10 mg/1.5 mL) must be used with the corresponding Omnitrope Pen 5 or Pen 10 delivery device
- Children generally receive injections 6 to 7 days per week; adults typically inject once daily — follow your prescriber's schedule exactly
- Treatment must be supervised by a physician experienced in diagnosing and managing the condition being treated
Show 2 more strengths Show fewer strengths
Oral solution
Topical cream, ointment or gel
📊 Somatropin across the U.S. market
How Somatropin appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Kit (85) · Powder (1) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
📈 How widely Somatropin is used
A general measure of how commonly Somatropin is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Somatropin is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Somatropin prescribed? Of the 1,596 medications we measure, Somatropin ranks #444 by Medicaid prescriptions — more than 72% of them.
Utilization by Somatropin product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
1.5 ML somatropin 6.67 MG/ML Pen Injector Most dispensed
Summed across the 1 of 2 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1736329
1.5 ML somatropin 10 MG/ML Pen Injector
Summed across the 1 of 2 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 847243
1 ML somatropin 12 MG/ML Cartridge
Summed across the 1 of 1 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 996558
1 ML somatropin 5 MG/ML Cartridge
Summed across the 1 of 1 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 763488
1.5 ML somatropin 3.33 MG/ML Pen Injector
Summed across the 1 of 2 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1736262
1.5 ML somatropin 6.67 MG/ML Cartridge
Summed across the 1 of 2 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1736337
somatropin 10 MG/ML Injectable Solution
Summed across the 1 of 3 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 284989
somatropin 5 MG/ML Injectable Solution
Summed across the 2 of 3 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 241975
somatropin 12 MG Cartridge
Summed across the 1 of 2 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 582969
1.5 ML somatropin 3.3 MG/ML Cartridge
Summed across the 1 of 2 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1736267
0.25 ML somatropin 2.4 MG/ML Prefilled Syringe
Summed across the 1 of 1 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 762837
somatropin 6 MG Cartridge
Summed across the 1 of 2 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 729232
0.25 ML somatropin 1.6 MG/ML Prefilled Syringe
Summed across the 1 of 1 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 762834
0.25 ML somatropin 0.8 MG/ML Prefilled Syringe
Summed across the 1 of 2 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 762830
somatropin 24 MG Cartridge
Summed across the 1 of 2 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 582974
0.25 ML somatropin 3.2 MG/ML Prefilled Syringe
Summed across the 1 of 1 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 762841
0.25 ML somatropin 4 MG/ML Prefilled Syringe
Summed across the 1 of 1 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 762873
somatropin 6 MG Injection
Summed across the 1 of 2 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 249453
0.25 ML somatropin 4.8 MG/ML Prefilled Syringe
Summed across the 1 of 1 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 762846
0.25 ML somatropin 5.6 MG/ML Prefilled Syringe
Summed across the 1 of 1 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 762850
0.25 ML somatropin 8 MG/ML Prefilled Syringe
Summed across the 1 of 1 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 762895
0.25 ML somatropin 6.4 MG/ML Prefilled Syringe
Summed across the 1 of 2 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 762857
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Somatropin, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 23 of 37 listed Somatropin NDCs with Medicaid activity.
🔍 Compare Somatropin products
A representative set of FDA-listed product records for Somatropin — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Injection | ||||
| 980 mcg/mg | — | Boehringer Ingelheim RCV GmbH & Co KG | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
| 5 mg/2 mL | Subcutaneous | Genentech, Inc. | BLA | View NDC → |
| 10 mg/2 mL | Subcutaneous | Genentech, Inc. | BLA | View NDC → |
| 20 mg/2 mL | Subcutaneous | Genentech, Inc. | BLA | View NDC → |
| 10 mg/1.5 mL | — | Novartis Pharmaceuticals Corporation | DRUG FOR FURTHER PROCESSING | View NDC → |
| 5 mg/1.5 mL | Subcutaneous | Novo Nordisk × 2 listings | BLA | View NDC → |
| 10 mg/1.5 mL | Subcutaneous | Novo Nordisk × 2 listings | BLA | View NDC → |
| 15 mg/1.5 mL | Subcutaneous | Novo Nordisk × 2 listings | BLA | View NDC → |
| 30 mg/3 mL | Subcutaneous | Novo Nordisk × 2 listings | BLA | View NDC → |
| 5 mg/1.5 mL | Subcutaneous | Sandoz Inc × 2 listings | BLA | View NDC → |
| 10 mg/1.5 mL | Subcutaneous | Sandoz Inc × 2 listings | BLA | View NDC → |
| 💊Oral solution | ||||
| 10 g/10 g | — | Bio-Technology General (Israel) Ltd. | BULK INGREDIENT | View NDC → |
| 5 g/2 L | — | Genentech, Inc. | DRUG FOR FURTHER PROCESSING | View NDC → |
| 60 g/60 g | — | Hefei Xinzhu Biological Technology Co., Ltd. | BULK INGREDIENT | View NDC → |
| 1 mg/mg | — | Jilin Qijian Bio-Pharmaceutical Co.,Ltd. | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Novartis Pharmaceuticals Corporation | BULK INGREDIENT | View NDC → |
| 10 mg | — | Wasserburger Arzneimittelwerk GmbH | DRUG FOR FURTHER PROCESSING | View NDC → |
| 💊Topical cream, ointment or gel | ||||
| 12 [hp_X]/mL | Topical | Viiva LLC | UNAPPROVED HOMEOPATHIC | Find on DailyMed ↗ |
| 💊Kits | ||||
| — | Intramuscular, Subcutaneous | Eli Lilly and Company × 6 listings | BLA | View NDC → |
| — | Intramuscular; Subcutaneous | Eli Lilly and Company × 6 listings | BLA | View NDC → |
| — | Subcutaneous | EMD Serono, Inc. × 7 listings | BLA | View NDC → |
| — | Intramuscular; Subcutaneous | EMD Serono, Inc. × 5 listings | BLA | View NDC → |
| — | — | Ferring Pharmaceuticals Inc. × 5 listings | BLA | View NDC → |
| — | Subcutaneous | Ferring Pharmaceuticals Inc. × 6 listings | BLA | View NDC → |
| — | — | Pfizer Laboratories Div Pfizer Inc × 36 listings | BLA | View NDC → |
| — | — | Pharmacia and Upjohn Company LLC × 12 listings | BLA | View NDC → |
| — | — | Sandoz Inc × 2 listings | BLA | View NDC → |
| 💊Bulk drug substance | ||||
| 1 g/g | — | Jilin Qijian Bio-Pharmaceutical Co.,Ltd. | BULK INGREDIENT | View NDC → |
Showing 110 of 110 products — FDA National Drug Code Directory. See every product, package size and price: browse all 110 Somatropin NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Somatropin — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Somatropin in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Somatropin went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 61148 5 dose forms · 32 strengths
-
Dose form (SCDF) Cartridge RxCUI 1734176No current FDA listingClinical drug / strength (SCD) 1 ML somatropin 12 MG/MLRxCUI 9965581 ML somatropin 5 MG/MLRxCUI 7634881.5 ML somatropin 3.3 MG/MLRxCUI 17362671.5 ML somatropin 6.67 MG/MLRxCUI 17363376 MGRxCUI 7292328.8 MGRxCUI 89704212 MGRxCUI 58296924 MGRxCUI 582974 -
Dose form (SCDF) Injectable Solution RxCUI 373935In current FDA listings -
Dose form (SCDF) Injection RxCUI 1734076In current FDA listings -
Dose form (SCDF) Pen Injector RxCUI 1735493In current FDA listingsClinical drug / strength (SCD) 1.5 ML somatropin 10 MG/MLRxCUI 8472431.5 ML somatropin 3.33 MG/MLRxCUI 17362621.5 ML somatropin 6.67 MG/MLRxCUI 17363292 ML somatropin 10 MG/MLRxCUI 17354942 ML somatropin 2.5 MG/MLRxCUI 8853852 ML somatropin 5 MG/MLRxCUI 17355363 ML somatropin 10 MG/MLRxCUI 849850 -
Dose form (SCDF) Prefilled Syringe RxCUI 727641No current FDA listingClinical drug / strength (SCD) 0.25 ML somatropin 0.8 MG/MLRxCUI 7628300.25 ML somatropin 1.6 MG/MLRxCUI 7628340.25 ML somatropin 2.4 MG/MLRxCUI 7628370.25 ML somatropin 3.2 MG/MLRxCUI 7628410.25 ML somatropin 4 MG/MLRxCUI 7628730.25 ML somatropin 4.8 MG/MLRxCUI 7628460.25 ML somatropin 5.6 MG/MLRxCUI 7628500.25 ML somatropin 6.4 MG/MLRxCUI 7628570.25 ML somatropin 7.2 MG/MLRxCUI 7628660.25 ML somatropin 8 MG/MLRxCUI 762895
Look up RxCUI 61148 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
📦 Supply & shortage status
Whether Somatropin is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏷️ Sold under these brand names
🏭 Manufacturers & labelers
RxNorm drug class
Somatropin belongs to the Recombinant Human Growth Hormone class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 5 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Novo Nordisk is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.